Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FM8RS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,063
Award facts
- Contract value 100% obligated
- $5,062.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors at a ceiling value of $5,062.58. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by October 16, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic areas. As a prime contractor under the DLA Troop Support Medical's global pharmaceutical support program, AmerisourceBergen fulfills medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award of this diabetes medication demonstrates the company's ongoing role in supporting military healthcare operations through competitively awarded delivery orders with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DB26FM8RS?
SPE2DB26FM8RS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 15, 2025.
How much is contract SPE2DB26FM8RS worth?
The government has obligated $5,063 on SPE2DB26FM8RS.
Is contract SPE2DB26FM8RS an order under another contract?
Yes. SPE2DB26FM8RS is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB26FM8RS competed?
The extent of competition for SPE2DB26FM8RS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award